STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. As an avid Pilates goer, I appreciated this story. The need-to-know this morning Roche reported a positive…

Read the full story at STAT ↗